2022.02.18
Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer's disease patients
(Nat Aging 2, 125-139 (2022). https://doi.org/10.1038/s43587-021-00158-9)
Takayuki Kondo T1,2,3, Hara N4, Satoshi Koyama S5, Yada Y2,3, Tsukita K2,3, Nagahashi A1,2, Ikeuchi T4, IshiiK6, Asada T7, Arai T7, Yamada R5, Alzheimer's Disease Neuroimaging Initiative (ADNI), Japanese Alzheimer's Disease Neuroimaging Initiative (J-ADNI) & Haruhisa Inoue1,2,3,8
1Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP)
2Center for iPS Cell Research and Application (CiRA), Kyoto University
3iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center (BRC)
4Department of Molecular Genetics, Brain Research Institute, Niigata University
5Unit of Statistical Genetics, Center for Genomic Medicine, Graduate School of Medicine, Kyoto University
6Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology
7Department of Psychiatry, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba
8Institute for Advancement of Clinical and Translational Science (iACT), Kyoto University Hospital
